Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
There are currently more than advanced therapies in the development pipeline globally along with approved therapies To enable this innovation and transformation of therapeutic options
Vogenx Inc a clinicalstage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases today announced completion of patient enrollment of a midPhase clinical dose
Iktos a company specialized in Artificial Intelligence for new drug design announces the opening of Iktos KK its new subsidiary in Japan Hideyoshi Fuji has been appointed Representative Director of Iktos KK and VicePresident
Brii Biosciences Limited a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs today announced that it has entered into agreements with VBI Vaccines Inc
EGenesis a biotechnology company developing humancompatible organs and cells for the treatment of organ failure and PorMedTec a global leader in porcine embryology have successfully produced genetically
GID BIO Inc completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own stromal vascular fraction cells to treat osteoarthritis of the knee The clinical study involves a cellular therapeutic
Nicox SA an international ophthalmology company today announced the signature of an agreement granting Kowa Company Ltd a Japanese company with a global pharmaceutical business
Auron Therapeutics a biotechnology company focused on developing nextgeneration targeted therapies by identifying and treating disrupted cell states of cancer today announced the nomination of its first development candidate
Zymedi announced today that the first in human dosage of ZMA a monoclonal antibody being developed as a firstinclass treatment for Pulmonary Arterial Hypertension has been initiated
Recce Pharmaceuticals Ltd the Company developing a new class of synthetic antiInfectives today announced it signed a Memorandum of Understanding with PT Etana Biotechnologies a leading Indonesian biomedical organization
